Experts talk realities, red flags of taking GLP-1 medications
The Corpus Christi Caller Times

Experts talk realities, red flags of taking GLP-1 medications

About 1 in 8 adults in the United States is currently taking a GLP-1 medication and nearly 1 in 5 has tried one, according to health care website Pabau. While medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) have become household names, the rush to snag one has sparked a growing div
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.